CTLA4 and non-small cell lung carcinoma: It has been reported that the EGFR and Hippo/YAP pathways are involved in regulation of PD‐L1 expression.14, 19, 25, 26, 27 We provided the evidence that anti‐CTLA4 antibody could induce PD‐L1 expression in NSCLC cells.